Minimally invasive neurostimulation device

US12257441B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12257441-B2
Application numberUS-202318307385-A
CountryUS
Kind codeB2
Filing dateApr 26, 2023
Priority dateJul 17, 2019
Publication dateMar 25, 2025
Grant dateMar 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Aspects of the present disclosure are directed to an implantable medical device including a housing containing components therein configured for delivering neurostimulation therapy, and an anchoring feature included with the housing. The implantable medical device also includes a lead having an electrode. In one aspect, the implantable medical device may include a guidewire passageway configured to allow the lead of implantable medical device to be introduced over a guidewire.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of implanting a tibial nerve stimulation device in an ankle region of a patient, the tibial nerve stimulation device including a housing and an electrical lead coupled to the housing, the electrical lead offset from the housing and including at least one electrode, a longitudinal axis of the housing generally oriented in the same direction as a longitudinal axis of the electrical lead, the method comprising: creating a first incision, in a skin of a patient superior and posterior to a medial malleolus on an ankle of the patient; creating a second incision, in a fascia layer in the ankle of the patient, the second incision being smaller than the first incision and the second incision sized to allow passage of the electrical lead therethrough; and advancing the implantable tibial nerve stimulation device through the first incision downward towards a heel of the patient and inward such that the electrical lead passes through the second incision, such that the housing of the implantable tibial nerve stimulation device is positioned superficial to the fascia layer and such that the at least one electrode is positioned below the fascia. 2. The method of claim 1 , further comprising advancing the implantable tibial nerve stimulation device through the first incision over a guidewire. 3. The method of claim 1 , wherein the electrical lead of the tibial nerve stimulation device includes a guidewire passageway extending from a proximal end of the electrical lead to a distal end of the electrical lead and being open on both ends such that a guidewire can extend outward from each end with the lead coupled to the housing, the method further comprising: advancing the implantable tibial nerve stimulation device through the first incision over a guidewire via the guidewire passageway in the electrical lead. 4. The method of claim 1 , further comprising implanting the implantable tibial nerve stimulation device such that the electrical lead longitudinal axis is generally oriented in the same direction as the housing longitudinal axis when implanted. 5. The method of claim 1 , wherein advancing the implantable tibial nerve stimulation device is performed using an implant tool including an outer sheath and an inner sheath, the inner sheath including a cradle portion configured to selectively carry the implantable tibial nerve stimulation device, the method further comprising: advancing the outer sheath of the implant tool toward a target implant location with respect to the inner sheath so as to deliver the implantable tibial nerve stimulation device to the target implant location. 6. The method of claim 1 , further comprising: performing testing of the implantable tibial nerve stimulation device, the testing including delivering a test stimulation and measuring an indicative patient response to the test stimulation.

Assignees

Inventors

Classifications

  • indicating steps of a surgical procedure · CPC title

  • Subcutaneous electrodes · CPC title

  • Anchoring or fixation means therefor · CPC title

  • Electrical supply · CPC title

  • Spinal or peripheral nerve electrodes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12257441B2 cover?
Aspects of the present disclosure are directed to an implantable medical device including a housing containing components therein configured for delivering neurostimulation therapy, and an anchoring feature included with the housing. The implantable medical device also includes a lead having an electrode. In one aspect, the implantable medical device may include a guidewire passageway configure…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/37235. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).